Blockade of the fractalkine-CX3CR1 axis ameliorates experimental colitis by dislodging venous crawling monocytes

Int Immunol. 2019 Apr 26;31(5):357. doi: 10.1093/intimm/dxz035.

Yoshikazu Kuboi^{1

2}, Miyuki Nishimura¹, Wataru Ikeda¹, Tomoya Nakatani¹, Yukie Seki³, Yui Yamaura³, Kana Ogawa¹, Akiko Hamaguchi¹, Kenzo Muramoto^{1

2

4}, Keiko Mizuno¹, Hideaki Ogasawara¹, Toshihiko Yamauchi^{1

2}, Nobuyuki Yasuda^{1

2}, Hiroshi Onodera⁵, Toshio Imai¹

¹ KAN Research Institute Inc., Minatojima-minamimachi, Chuo-ku, Kobe, Hyogo, Japan.
² Tsukuba Research Laboratories, Eisai Co., Ltd., Tsukuba, Ibaraki, Japan.
³ Research Institute, EA Pharma Co., Ltd., Suzuki-cho, Kawasaki-ku, Kawasaki-shi, Kanagawa, Japan.
⁴ Medical Communication Section, Medical Division, Eisai Co., Ltd., Bunkyo-ku, Tokyo, Japan.
⁵ Photon Science Center of the University of Tokyo, Department of Electrical Engineering and Information System, Graduate School of Engineering, Bunkyo-ku, Tokyo, Japan.

No abstract available

Publication types